259 related articles for article (PubMed ID: 17443640)
1. Comparative proteomic analysis of human pancreatic juice: methodological study.
Zhou L; Lu Z; Yang A; Deng R; Mai C; Sang X; Faber KN; Lu X
Proteomics; 2007 Apr; 7(8):1345-55. PubMed ID: 17443640
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis of protein expression in human tonsillar cancer: differentially expressed proteins characterize human tonsillar cancer.
Roblick UJ; Bader FG; Hammarstedt L; Habermann JK; Hellman U; Becker S; Sundmacker A; Gemoll T; Zimmermann K; Auer G; Munck-Wikland E
Acta Oncol; 2008; 47(8):1493-501. PubMed ID: 18759147
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
Chung JC; Oh MJ; Choi SH; Bae CD
ANZ J Surg; 2008 Apr; 78(4):245-51. PubMed ID: 18366394
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of human bile from malignant biliary stenosis induced by pancreatic cancer.
Farina A; Dumonceau JM; Frossard JL; Hadengue A; Hochstrasser DF; Lescuyer P
J Proteome Res; 2009 Jan; 8(1):159-69. PubMed ID: 19055478
[TBL] [Abstract][Full Text] [Related]
5. Protein profiling in pancreatic juice for detection of intraductal papillary mucinous neoplasm of the pancreas.
Shirai Y; Sogawa K; Yamaguchi T; Sudo K; Nakagawa A; Sakai Y; Ishihara T; Sunaga M; Nezu M; Tomonaga T; Miyazaki M; Saisho H; Nomura F
Hepatogastroenterology; 2008; 55(86-87):1824-9. PubMed ID: 19102401
[TBL] [Abstract][Full Text] [Related]
6. Quantitative proteomic profiling of pancreatic cancer juice.
Chen R; Pan S; Yi EC; Donohoe S; Bronner MP; Potter JD; Goodlett DR; Aebersold R; Brentnall TA
Proteomics; 2006 Jul; 6(13):3871-9. PubMed ID: 16739137
[TBL] [Abstract][Full Text] [Related]
7. Two-dimensional electrophoresis for comparative proteomic analysis of human bile.
Chen B; Dong JQ; Chen YJ; Wang JM; Tian J; Wang CB; Zou SQ
Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):402-6. PubMed ID: 17690038
[TBL] [Abstract][Full Text] [Related]
8. [Immuno-proteomic screening of human pancreatic cancer associated membrane antigens for early diagnosis].
Ning L; Pan B; Zhao YP; Liao Q; Zhang TP; Chen G; Wang WB; Yang YC
Zhonghua Wai Ke Za Zhi; 2007 Jan; 45(1):34-8. PubMed ID: 17403287
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease.
Matsubayashi H; Canto M; Sato N; Klein A; Abe T; Yamashita K; Yeo CJ; Kalloo A; Hruban R; Goggins M
Cancer Res; 2006 Jan; 66(2):1208-17. PubMed ID: 16424060
[TBL] [Abstract][Full Text] [Related]
10. Transthyretin, identified by proteomics, is overabundant in pancreatic juice from pancreatic carcinoma and originates from pancreatic islets.
Lv S; Gao J; Zhu F; Li Z; Gong Y; Xu G; Ma L
Diagn Cytopathol; 2011 Dec; 39(12):875-81. PubMed ID: 20949480
[TBL] [Abstract][Full Text] [Related]
11. Do cytokine concentrations in pancreatic juice predict the presence of pancreatic diseases?
Noh KW; Pungpapong S; Wallace MB; Woodward TA; Raimondo M
Clin Gastroenterol Hepatol; 2006 Jun; 4(6):782-9. PubMed ID: 16713745
[TBL] [Abstract][Full Text] [Related]
12. Clinical cancer proteomics: promises and pitfalls.
Alaiya A; Al-Mohanna M; Linder S
J Proteome Res; 2005; 4(4):1213-22. PubMed ID: 16083271
[TBL] [Abstract][Full Text] [Related]
13. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R
Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941
[TBL] [Abstract][Full Text] [Related]
14. Proteomics of pancreatic cancer.
Gräntzdörffer I; Carl-McGrath S; Ebert MP; Röcken C
Pancreas; 2008 May; 36(4):329-36. PubMed ID: 18437077
[TBL] [Abstract][Full Text] [Related]
15. S100A6 is increased in a stepwise manner during pancreatic carcinogenesis: clinical value of expression analysis in 98 pancreatic juice samples.
Ohuchida K; Mizumoto K; Yu J; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):649-54. PubMed ID: 17416753
[TBL] [Abstract][Full Text] [Related]
16. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.
Pei H; Zhu H; Zeng S; Li Y; Yang H; Shen L; Chen J; Zeng L; Fan J; Li X; Gong Y; Shen H
J Proteome Res; 2007 Jul; 6(7):2495-501. PubMed ID: 17542627
[TBL] [Abstract][Full Text] [Related]
17. Mining the malignant ascites proteome for pancreatic cancer biomarkers.
Kosanam H; Makawita S; Judd B; Newman A; Diamandis EP
Proteomics; 2011 Dec; 11(23):4551-8. PubMed ID: 21932441
[TBL] [Abstract][Full Text] [Related]
18. In situ telomerase activity in pancreatic juice may discriminate pancreatic cancer from other pancreatic diseases.
Uehara H; Nakaizumi A; Iishi H; Takenaka A; Eguchi H; Ohigashi H; Ishikawa O
Pancreas; 2008 Apr; 36(3):236-40. PubMed ID: 18362835
[TBL] [Abstract][Full Text] [Related]
19. Telomerase activity detected in pancreatic juice 19 months before a tumor is detected in a patient with pancreatic cancer.
Suehara N; Mizumoto K; Kusumoto M; Niiyama H; Ogawa T; Yamaguchi K; Yokohata K; Tanaka M
Am J Gastroenterol; 1998 Oct; 93(10):1967-71. PubMed ID: 9772067
[TBL] [Abstract][Full Text] [Related]
20. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
